Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2007

01-04-2007 | Original Paper

The black:white disparity in breast cancer mortality: the example of Chicago

Authors: Jocelyn Hirschman, Steven Whitman, David Ansell

Published in: Cancer Causes & Control | Issue 3/2007

Login to get access

Abstract

Objective

The black:white disparity in breast cancer mortality has been increasing in the U.S. In order to gain insight into this disparity in Chicago, we examined mortality data together with other important measures associated with breast cancer.

Methods

Trends in black:white female breast cancer mortality, incidence, stage at diagnosis, and mammography screening in Chicago were examined using data from the Illinois State Cancer Registry, Illinois Department of Public Health Vital Records, and the Illinois Behavioral Risk Factor Surveillance System.

Results

The breast cancer mortality rate for black women in Chicago for 1999–2003 was 49% higher than that of white women, but the disparity is a recent phenomenon that is increasing rapidly. In 2003 the black rate was 68% higher than the white rate. Mortality rates were similar in the 1980’s and only started to diverge in the 1990’s as a result of a sharp improvement in mortality among white women contrasted with no improvement for black women. This lack of progress for black women is perplexing given that self-reported mammography screening rates have been the same for blacks and whites in Chicago since at least 1996 and that the early detection of breast cancer for black women has been increasing.

Conclusions

There has been no improvement in mortality from breast cancer for black women in Chicago in 23 years. This study, along with a review of the literature, lends support to the hypothesis that the disparities in breast cancer mortality are due to differential access to mammography, differential quality in mammography, and differential access to treatment for breast cancer. Fortunately, all three are amenable to intervention, which would help ameliorate this unacceptable disparity.
Literature
1.
American Cancer Society (2004) Breast cancer facts and figures, 2004. American Cancer Society, Inc., Atlanta, GA
2.
Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics. 2002. CA Cancer J Clin 52:23–47PubMed
3.
U. S. Department of Health and Human Services (1991) Healthy people 2000: national health promotion and disease prevention objectives. U.S. Government Printing Office, Washington, DC
4.
U.S. Department of Health and Human Services (2000) Healthy people 2010: understanding and improving health and objectives for improving health. U.S. Government Printing Office, Washington, DC
5.
Bigby J, Holmes MD (2005) Disparities across the breast cancer continuum. Cancer Causes Control 16:35–44PubMedCrossRef
6.
Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141–148PubMedCrossRef
7.
Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP (2000) Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 89:2202–2213PubMedCrossRef
8.
Joslyn SA (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95:1759–1766PubMedCrossRef
9.
Hoyert DL, Heron MP, Murphy SL, Kung H (2006) Deaths: final data for 2003. National vital statistics reports: vol 54 no 13. National Center for Health Statistics, Hyattsville, MD
10.
Margellos H, Silva A, Whitman S (2004) Comparison of health status indicators in Chicago: are black-white disparities worsening? Am J Public Health 94:116–121PubMedCrossRef
11.
12.
13.
Tyczynski JE, Hill TD, Berkel HJ (2006) Why do postmenopausal African-American women not benefit from overall breast cancer mortality decline? Ann Epidemiol 16:180–190PubMedCrossRef
14.
15.
Illinois Department of Public Health, Illinois State Cancer Registry (2004) Cancer incidence data 1986–2002; data as of November 2004
16.
Percy C, Van Holten V, Muir C (1990) International classification of diseases for oncology, 2nd edn. World Health Organization, Geneva, Switzerland
17.
Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva, Switzerland
18.
Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbert A (eds) (2001) SEER summary staging manual – 2001: codes and coding instructions. National Cancer Institute, Bethesda, MD. NIH Pub. No. 01-4969
19.
ICD-9-CM Codebook 2001, 6th edn (2000) Vols 1, 2 & 3. St. Anthony’s Publishing, Reston, VA
20.
21.
Nelson DE, Holtzman D, Waller M, Leutzinger C, Condon K (1998) Objectives and design of the Behavioral Risk Factor Surveillance System. Paper presented at American Statistical Association National Meeting, Dallas TX
22.
Ries LAG, Eisner MP, Kosary CL et al (eds) SEER cancer statistics review, 1975–2002. National Cancer Institute, Bethesda, MD. Available from URL: http://​seer.​cancer.​gov/​csr/​1975_​2002/​. Based on November 2004 SEER data submission, posted to the SEER web site 2005 [accessed 11 July 2006]
23.
24.
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351 (correction: 2001; 20:655)PubMedCrossRef
25.
Richardson LC, Schulman J, Sever LE, Lee NC, Coate RJ (2001) Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program. Breast Cancer Res Treat 69:133–142PubMedCrossRef
26.
Nasseri K (2004) Secular trends in the incidence of female breast cancer in the United States, 1973–1998. Breast J 10(2):129–135PubMedCrossRef
27.
Harris DH, Bates JH, Cress R, Tabnak F, Wright WE (2004) Stage of breast cancer diagnosis among medically underserved women in California receiving mammography through a state screening program. Cancer Causes Control 15:721–729PubMedCrossRef
28.
Ernster VL, Barclay B, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913–918PubMedCrossRef
29.
Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554PubMed
30.
31.
Chiang CL (1961) Standard error of the age-adjusted death rate. Vital Stat Selected Rep 47:275–285
32.
Rothman KJ (1986) Modern epidemiology. Little, Brown and Company, Boston, MA
33.
Keppel KG, Pearcy JN, Wagener DK (2002) Trends in racial and ethnic-specific rates for the Health Status Indicators: United States, 1990–98. In: Healthy people statistical notes. No. 23. National Center for Health Statistics, Hyattsville, MD
34.
Chu KC, Tarone RE, Brawley OW (1999) Breast cancer trends of black women compared with white women. Arch Fam Med 8:521–528PubMedCrossRef
35.
Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93:1704–1713PubMedCrossRef
36.
Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792PubMedCrossRef
37.
Cooper R, Cutler J, Desvigne-Nickens P et al (2000) Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102:3137–3147PubMed
38.
39.
Coughlin SS, Uhler RJ, Bobo JK, Caplan L (2004) Breast cancer screening practices among women in the United States, 2000. Cancer Causes Control 15:159–170PubMedCrossRef
40.
Centers for Disease Control and Prevention (2005) Breast cancer screening and socioeconomic status – 35 metropolitan areas, 2000 and 2002. MMWR 54:981–985
41.
Norman SA, Localio AR, Zhou L et al (2003) Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol 158(3):264–271PubMedCrossRef
42.
Carney PA, Goodrich ME, Mackenzie T et al (2005) Utilization of screening mammography in New Hampshire. Cancer 104(8):1726–1732PubMedCrossRef
43.
Armstrong K, Long JA, Shea JA (2004) Measuring adherence to mammography screening recommendations among low-income women. Prev Med 38(6):754–760PubMedCrossRef
44.
Caplan LS, Mandelson MT, Anderson LA (2003) Validity of self-reported mammography: examining recall and covariates among older women in a health maintenance organization. Am J Epidemiol 157:267–272PubMedCrossRef
45.
Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N (2003) Validity of women’s self-report of cancer screening test utilization in a managed care population. Cancer Epi Bio Prev 12:1182–1187
46.
Fiscella K, Franks P, Meldrum S (2004) Estimating racial/ethnic disparity in mammography rates: it all depends on how you ask the question. Prev Med 39:399–403PubMedCrossRef
47.
Kagay CR, Quale C, Smith-Bindman R (2006) Screening mammography in the American elderly. Am J Prev Med 31(2):142–149PubMedCrossRef
48.
Peek ME, Han JH (2004) Disparities in screening mammography: current status, interventions, and implications. J Gen Intern Med 19:184–194PubMedCrossRef
49.
Jones BA, Patterson EA, Calvocoressi (2003) Mammogram screening in African American women: evaluating the research. Cancer 97(1 Suppl):258–272PubMedCrossRef
50.
Smith-Bindman R, Miglioretti DL, Lurie N et al (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541–553PubMed
51.
Nass S, Ball J (eds) (2005) Improving breast imaging quality standards. The National Academies Press, Washington, DC
52.
May DS, Lee NC, Richardson LC, Giustozzi AG, Bobo JK (2000) Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States). Cancer Causes Control 11:697–705PubMedCrossRef
53.
Wang H, Karesen R, Hervik A, Thoresen SO (2001) Mammography screening in Norway: results from the first screening round in four countries and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control 12:39–45PubMedCrossRef
54.
NHS Breast Screening Programme (2003) Serving women for 15 years. Patnick J (ed). NHSBSP, Sheffield, England. Available from URL: www.cancerscreening.nhs.uk [accessed 17 July 2006]
55.
Moss M, Steinhauer J (2002) “Mammogram clinic’s flaws highlight gaps in U.S. rules.” The New York Times 24:A1
56.
Centers for Disease Control and Prevention (2004) Breast cancer – screening data for assessing quality of services – New York, 2000–2003. MMWR 53(21):455–457
57.
Jones BA, Culler CS, Kasi SV, Calvocoressi L (2001) Is variation in quality of mammographic services race linked? J Health Care Poor Underserved 12:113–126PubMed
58.
Smedley BA, Stith AY, Nelson AR (eds) (2003) Unequal treatment: confronting racial and ethnic disparities in health care. National Academies Press, Washington, DC
59.
Williams DR (1999) Race, socioeconomic status, and health: the added effects of racism and discrimination. Ann NY Acad Sci 896:173–188PubMedCrossRef
60.
61.
Bloche MG (2004) Health care disparities: science, politics, and race. N Engl J Med 350:1574–1576CrossRef
62.
Cunningham JE, Butler WM (2004) Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 88:161–176PubMedCrossRef
63.
64.
Brawley OW (2002) Disaggregating the effects of race and poverty on breast cancer outcomes. J Nat Cancer Inst 94:471–473PubMed
65.
Digman J, Redmont C, Fisher B, Constantino J, Edwards B (1997) Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel project (NSABP). Cancer 80:80–90CrossRef
66.
Shavers VL, Brown ML (2002) Racial and ethnic disparities in receipt of cancer treatment. J Natl Cancer Inst 94:334–357PubMed
67.
Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW (2003) Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81:21–31PubMedCrossRef
68.
Jones BA, Dailey A, Calvocoressi L et al (2005) Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control 16:809–821PubMedCrossRef
69.
Yankaskas BC, Klabunde CN, Ancelle-Par R et al (2004) International comparison of performance measures for screening mammography: can it be done? J Med Screening 11:187–193CrossRef
70.
Sickles EA, Wolverton DE, Dee KE (2002) Performance parameters for screening and diagnostic mammography: specials and general radiologists. Radiology 224:861–869PubMed
71.
Sipkoff M (2004) Transparency called key to uniting cost control, quality improvement. Managed Care 13(1):38–42PubMed
72.
Li C, Daling J, Malone K (2003) Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 22:47–53
73.
Allen TW (1994) The invention of the white race. Verso Press, New York, NY
74.
75.
Freeman HP (1998) The meaning of race in science – considerations for cancer research. Cancer 82:219–225PubMedCrossRef
76.
Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24:2170–2178PubMedCrossRef
77.
Brawley OW, Freeman HP (1999) Race and outcomes: is this the end of the beginning for minority health research? J Natl Cancer Inst 91:1433–1440CrossRef
Metadata
Title
The black:white disparity in breast cancer mortality: the example of Chicago
Authors
Jocelyn Hirschman
Steven Whitman
David Ansell
Publication date
01-04-2007
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 3/2007
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0102-y

Other articles of this Issue 3/2007

Cancer Causes & Control 3/2007 Go to the issue

Original Paper

Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries

Review Article

Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods

Original Paper

Screening for prostate cancer: A Cochrane systematic review

Original Paper

Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort

Original Paper

Ambient UV, personal sun exposure and risk of multiple primary melanomas

Original Paper

Psychological attitudes and risk of breast cancer in Japan: a prospective study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits